Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis.

Curtis KA, Kennedy MS, Luckay A, Cong ME, Youngpairoj AS, Zheng Q, Smith J, Hanson D, Heneine W, Owen SM, García-Lerma JG.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):355-62. doi: 10.1097/QAI.0b013e3182234a51.

PMID:
21637113
[PubMed - indexed for MEDLINE]
2.

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.

van de Vijver DA, Boucher CA.

Curr Opin Infect Dis. 2010 Dec;23(6):621-7. doi: 10.1097/QCO.0b013e32833ff1e6. Review.

PMID:
20847692
[PubMed - indexed for MEDLINE]
3.

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.

Ruprecht RM, Hofmann-Lehmann R, Smith-Franklin BA, Rasmussen RA, Liska V, Vlasak J, Xu W, Baba TW, Chenine AL, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Montefiori DC, McClure HM.

Transfus Clin Biol. 2001 Aug;8(4):350-8. Review.

PMID:
11642027
[PubMed - indexed for MEDLINE]
4.

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

Myers GM, Mayer KH.

AIDS Patient Care STDS. 2011 Feb;25(2):63-71. doi: 10.1089/apc.2010.0222. Review.

PMID:
21284497
[PubMed - indexed for MEDLINE]
5.

Animal models of antiretroviral prophylaxis for HIV prevention.

García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2012 Nov;7(6):505-13. doi: 10.1097/COH.0b013e328358e484. Review.

PMID:
22964889
[PubMed - indexed for MEDLINE]
6.

[HIV preexposure prophylaxis].

Olczak A, Grabczewska E.

Przegl Epidemiol. 2012;66(1):79-82. Review. Polish.

PMID:
22708303
[PubMed - indexed for MEDLINE]
Free Article
7.

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Baeten JM, Haberer JE, Liu AY, Sista N.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9. doi: 10.1097/QAI.0b013e3182986f69. Review.

PMID:
23764623
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
[PubMed - indexed for MEDLINE]
9.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
[PubMed - indexed for MEDLINE]
10.

Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.

Nadery S, Geerlings SE.

Neth J Med. 2013 Jul-Aug;71(6):295-9. Review.

PMID:
23956310
[PubMed - indexed for MEDLINE]
Free Article
11.

HIV prevention by oral preexposure prophylaxis.

Heneine W, Kashuba A.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419. doi: 10.1101/cshperspect.a007419. Review.

PMID:
22393535
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence.

Blumenthal J, Haubrich R.

Expert Opin Pharmacother. 2013 Sep;14(13):1777-85. doi: 10.1517/14656566.2013.812072. Epub 2013 Jun 26. Review.

PMID:
23800167
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

HIV prevention in southern Africa: why we must reassess our strategies?

Katsidzira L, Hakim JG.

Trop Med Int Health. 2011 Sep;16(9):1120-30. doi: 10.1111/j.1365-3156.2011.02807.x. Epub 2011 Jun 12. Review.

PMID:
21668592
[PubMed - indexed for MEDLINE]
Free Article
14.

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Molina JM, Pintado C, Gatey C, Ponscarme D, Charbonneau P, Loze B, Rozenbaum W, Delaugerre C.

BMC Med. 2013 Aug 23;11:186. doi: 10.1186/1741-7015-11-186. Review.

PMID:
23972284
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Next-generation oral preexposure prophylaxis: beyond tenofovir.

Abraham BK, Gulick R.

Curr Opin HIV AIDS. 2012 Nov;7(6):600-6. doi: 10.1097/COH.0b013e328358b9ce. Review.

PMID:
23032733
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The clinical pharmacology of antiretrovirals for HIV prevention.

Hendrix CW.

Curr Opin HIV AIDS. 2012 Nov;7(6):498-504. doi: 10.1097/COH.0b013e32835847ae. Review.

PMID:
22964888
[PubMed - indexed for MEDLINE]
17.

A pill for HIV prevention: déjà vu all over again?

Myers JE, Sepkowitz KA.

Clin Infect Dis. 2013 Jun;56(11):1604-12. doi: 10.1093/cid/cit085. Epub 2013 Feb 13. Review.

PMID:
23408681
[PubMed - indexed for MEDLINE]
Free Article
18.

Pre-exposure prophylaxis--one more tool for HIV prevention.

Person AK, Hicks CB.

Curr HIV Res. 2012 Mar;10(2):117-22. Review.

PMID:
22329517
[PubMed - indexed for MEDLINE]
19.

Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.

Dimitrov D, Boily MC, Brown ER, Hallett TB.

PLoS One. 2013 Nov 25;8(11):e80927. doi: 10.1371/journal.pone.0080927. eCollection 2013. Review.

PMID:
24282559
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk